Home
Conditions
Systemic Vasculitis

Clinical trial condition

Systemic Vasculitis

Explore clinical trials studying Systemic Vasculitis. Study availability and eligibility vary by location and protocol.

183 public trials 63 recruiting studies

Refine in advanced search Browse all conditions

Systemic Vasculitis trial results

Not Yet Recruiting

Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)

NCT06226662

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases

NCT06821659

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arthritis, +31 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases

NCT06420154

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome, +32 more
Locations: The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China

View Trial Details

Completed

Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3

NCT07712172

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations: Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh Chandigarh, India

View Trial Details

Completed

Retrospective Analysis of Systemic Glucocorticoid Mediated Long-term Effects, Patient Pathways and Economic Burden Across Multiple Indications

NCT06488703

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Asthma, Autoimmune Diseases, +37 more
Locations: Rwth Aachen University-Aachen-Germany-C Germany

View Trial Details

Completed

Effectiveness on Sino-Nasal Symptoms Of Mepolizumab 300

NCT07592104

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +19 more
Locations: Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Italy

View Trial Details

Completed

Long-Term Safety and Effectiveness of Mepolizumab 300 mg in Europe (Mepo LTF Study)

NCT07591753

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations: University of Florence Florence, Italy

View Trial Details

Completed

Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis

NCT03920722

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +14 more
Locations: Cochin Hospital Paris, France

View Trial Details

Completed

Study of One Protein Implicated in Wegener Disease

NCT01167491

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations: Medecine Interne Hôpital Saint Louis Paris, France

View Trial Details

Completed

The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach

NCT01940094

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Mayo Clinic Rochester, Minnesota, United States

Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Systemic Vasculitis

Systemic Vasculitis trial results

Related conditions